Back to Journals » Drug Design, Development and Therapy » Volume 3

Drug Design, Development and Therapy


Archive: Volume 3, 2009

Review of the pharmacology and clinical studies of micafungin

Alison M Bormann, Vicki A Morrison

Drug Design, Development and Therapy 2009, 3:295-302

Published Date: 10 December 2009

Effect of combinations of antiviral drugs on herpes simplex encephalitis

Bryan M Gebhardt, Federico Focher, Richard Eberle, et al

Drug Design, Development and Therapy 2009, 3:289-294

Published Date: 9 December 2009

Conivaptan and its role in the treatment of hyponatremia

Jalal K Ghali, Jareer O Farah, Suleiman Daifallah, et al

Drug Design, Development and Therapy 2009, 3:253-268

Published Date: 16 October 2009

Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia

Ann Janssens, Marc Boogaerts, Gregor Verhoef

Drug Design, Development and Therapy 2009, 3:241-252

Published Date: 14 October 2009

A review of exenatide as adjunctive therapy in patients with type 2 diabetes

Gisela I Robles, Devada Singh-Franco

Drug Design, Development and Therapy 2009, 3:219-240

Published Date: 10 September 2009

Long-term disease-free survivor of metastatic large-cell neuroendocrine carcinoma of the lung treated with amrubicin and irinotecan

Shinichiro Ryuge, Shi-Xu Jiang, Mayuko Wada, Ken Katono, et al.

Drug Design, Development and Therapy 2009, 3:213-217

Published Date: 13 July 2009

T10B9 monoclonal antibody: A short-acting nonstimulating monoclonal antibody that spares γδ T-cells and treats and prevents cellular rejection

Thomas H Waid, John S Thompson, Maria Siemionow, Stephen A Brown

Drug Design, Development and Therapy 2009, 3:205-212

Published Date: 25 June 2009

Pleiotropic vasoprotective effects of statins: The chicken or the egg?

Dimitrios Kirmizis, Dimitrios Chatzidimitriou

Drug Design, Development and Therapy 2009, 3:191-204

Published Date: 10 June 2009

Characteristics of doripenem: a new broad-spectrum antibiotic

Francisco Alvarez-Lerma, Santiago Grau, Olivia Ferrández

Drug Design, Development and Therapy 2009, 3:173-190

Published Date: 27 May 2009

Efficacy of epicutaneous Diractin® (ketoprofen in Transfersome® gel) for the treatment of pain related to eccentric muscle contractions

Matthias Rother, Egbert J Seidel, Priscilla M Clarkson, Stefan Mazgareanu, et al.

Drug Design, Development and Therapy 2009, 3:143-149

Published Date: 19 May 2009

Indiplon in the management of insomnia

Michael D Lemon, Joe D Strain, Annie M Hegg, Debra K Farver

Drug Design, Development and Therapy 2009, 3:131-142

Published Date: 8 May 2009

Selective reversal of muscle relaxation in general anesthesia: focus on sugammadex

Sorin J Brull, Mohamed Naguib

Drug Design, Development and Therapy 2009, 3:119-129

Published Date: 24 April 2009

Oxidative stress-induced cell cycle blockage and a protease-independent programmed cell death in  microaerophilic Giardia lamblia

Esha Ghosh, Arjun Ghosh, Amar Nath Ghosh, Tomoyoshi Nozaki, Sandipan Ganguly

Drug Design, Development and Therapy 2009, 3:103-110

Published Date: 26 March 2009

Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib

Ronan Swords, Devalingam Mahalingam, Swaminathan Padmanabhan, Jennifer Carew, Francis Giles

Drug Design, Development and Therapy 2009, 3:89-101

Published Date: 27 March 2009

Troglitazone reverses the multiple drug resistance phenotype in cancer cells

Gerald F Davies, Bernhard HJ Juurlink, Troy AA Harkness

Drug Design, Development and Therapy 2009, 3:79-88

Published Date: 17 March 2009

Analysis of HSP90-related folds with MED-SuMo classification approach

Olivia Doppelt-Azeroual, Fabrice Moriaud, François Delfaud, Alexandre G de Brevern

Drug Design, Development and Therapy 2009, 3:59-72

Published Date: 26 February 2009

Alitretinoin – its use in intractable hand eczema and other potential indications

Bibi Petersen, Gregor BE Jemec

Drug Design, Development and Therapy 2009, 3:51-57

Published Date: 5 February 2009

The evolving role of alemtuzumab (Campath-1H) in renal transplantation

Phuong-Thu T Pham, Gerald S Lipshutz, Phuong-Truc T Pham, Joseph Kawahji, Jennifer S Singer, Phuong-Chi T Pham

Drug Design, Development and Therapy 2009, 3:41-49

Published Date: 23 December 2008

Apoptotic and chemotherapeutic properties of iron(III)-salophene in an ovarian cancer animal model

Thilo S Lange, Carolyn McCourt, Rakesh K Singh, Kyu Kwang Kim, Ajay P Singh, et al

Drug Design, Development and Therapy 2009, 3:17-26

Published Date: 17 December 2008

Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC

Akito Natsume, Rinpei Niwa, Mitsuo Satoh

Drug Design, Development and Therapy 2009, 3:7-16

Published Date: 16 December 2008